Predicting Development of SCAF in Device Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predicting Development of SCAF in Device Patients — Stella

Recruiting

Back to Atrial Fibrillation trials

Trial locations(1 site)

Canada

University of Ottawa Heart Institute, Ottawa, Ontario

Key details

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators

Genome Canada

Enrollment target

~500 participants

Started

September 2022

Primary completion

September 2034

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov